Maple Capital Management Inc. lifted its stake in shares of Becton, Dickinson and Company (NYSE:BDX) by 56.3% in the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 1,665 shares of the medical instruments supplier’s stock after buying an additional 600 shares during the quarter. Maple Capital Management Inc. owned about 731.64% of Becton, Dickinson and worth $326,000 at the end of the most recent reporting period.

Several other large investors also recently modified their holdings of the company. Almanack Investment Partners LLC. purchased a new stake in Becton, Dickinson and in the 1st quarter valued at $105,000. Mitsubishi UFJ Securities Holdings Co. Ltd. raised its position in Becton, Dickinson and by 55.8% in the 2nd quarter. Mitsubishi UFJ Securities Holdings Co. Ltd. now owns 670 shares of the medical instruments supplier’s stock valued at $131,000 after purchasing an additional 240 shares during the last quarter. Parkside Financial Bank & Trust raised its position in Becton, Dickinson and by 8.1% in the 2nd quarter. Parkside Financial Bank & Trust now owns 684 shares of the medical instruments supplier’s stock valued at $133,000 after purchasing an additional 51 shares during the last quarter. Harfst & Associates Inc. raised its position in Becton, Dickinson and by 46.4% in the 2nd quarter. Harfst & Associates Inc. now owns 697 shares of the medical instruments supplier’s stock valued at $135,000 after purchasing an additional 221 shares during the last quarter. Finally, Financial Architects Inc raised its position in Becton, Dickinson and by 8.0% in the 2nd quarter. Financial Architects Inc now owns 731 shares of the medical instruments supplier’s stock valued at $142,000 after purchasing an additional 54 shares during the last quarter. Institutional investors and hedge funds own 86.01% of the company’s stock.

In other news, insider Gary M. Cohen sold 15,512 shares of the company’s stock in a transaction on Monday, September 11th. The shares were sold at an average price of $203.77, for a total transaction of $3,160,880.24. Following the transaction, the insider now directly owns 95,781 shares of the company’s stock, valued at approximately $19,517,294.37. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, insider Gary M. Cohen sold 15,044 shares of the company’s stock in a transaction on Tuesday, August 22nd. The stock was sold at an average price of $200.43, for a total transaction of $3,015,268.92. Following the transaction, the insider now directly owns 95,270 shares in the company, valued at $19,094,966.10. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 53,187 shares of company stock worth $10,720,847. Corporate insiders own 1.40% of the company’s stock.

Several analysts recently commented on the stock. Barclays PLC reiterated an “equal weight” rating and issued a $210.00 price target (up previously from $205.00) on shares of Becton, Dickinson and in a research report on Thursday, August 10th. BidaskClub downgraded shares of Becton, Dickinson and from a “strong-buy” rating to a “buy” rating in a research report on Monday, July 31st. Zacks Investment Research upgraded shares of Becton, Dickinson and from a “sell” rating to a “hold” rating in a research report on Friday, October 20th. Stifel Nicolaus reiterated a “buy” rating on shares of Becton, Dickinson and in a research report on Wednesday, August 9th. Finally, Piper Jaffray Companies reiterated a “buy” rating and issued a $213.00 price target on shares of Becton, Dickinson and in a research report on Tuesday, September 12th. Five analysts have rated the stock with a hold rating, ten have given a buy rating and one has given a strong buy rating to the company. The stock currently has a consensus rating of “Buy” and an average price target of $213.47.

WARNING: This piece was originally published by Watch List News and is owned by of Watch List News. If you are accessing this piece on another site, it was illegally stolen and republished in violation of U.S. and international trademark and copyright legislation. The correct version of this piece can be read at https://www.watchlistnews.com/becton-dickinson-and-company-bdx-stake-increased-by-maple-capital-management-inc/1699992.html.

Becton, Dickinson and Company (NYSE BDX) opened at $218.04 on Monday. The company has a debt-to-equity ratio of 1.48, a quick ratio of 5.01 and a current ratio of 5.56. Becton, Dickinson and Company has a 12 month low of $161.29 and a 12 month high of $225.23. The firm has a market cap of $49,889.07, a price-to-earnings ratio of 23.10, a PEG ratio of 1.72 and a beta of 1.04.

Becton, Dickinson and (NYSE:BDX) last posted its quarterly earnings results on Thursday, November 2nd. The medical instruments supplier reported $2.40 earnings per share for the quarter, topping the Zacks’ consensus estimate of $2.37 by $0.03. Becton, Dickinson and had a net margin of 8.52% and a return on equity of 22.51%. The business had revenue of $3.17 billion for the quarter, compared to analysts’ expectations of $3.14 billion. During the same period in the prior year, the company posted $2.12 EPS. The business’s revenue for the quarter was down 2.0% on a year-over-year basis. research analysts predict that Becton, Dickinson and Company will post 10.63 earnings per share for the current year.

Becton, Dickinson and Company Profile

Becton, Dickinson and Company (BD) is a global medical technology company engaged in the development, manufacture and sale of a range of medical supplies, devices, laboratory equipment and diagnostic products. The Company operates through two segments: BD Medical and BD Life Sciences. The BD Medical segment produces an array of medical technologies and devices that are used to help improve healthcare delivery in a range of settings.

Institutional Ownership by Quarter for Becton, Dickinson and (NYSE:BDX)

Receive News & Ratings for Becton Dickinson and Company Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Becton Dickinson and Company and related companies with Analyst Ratings Network's FREE daily email newsletter.